Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

Showing session: reset

Concurrent Session 4: Targeting the Innate Immune System

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 3 of 3
Concurrent Session 4: Targeting the Innate Immune System
Integrating anti-GD2 therapies and fusokines with NK cells for pediatric solid tumors
Christian M Capitini
University of Wisconsin, Madison, WI, United States
from 2019 Molecular Targets and Cancer Therapeutics conference on October 28, 2019 4:15 PM-6:00 PM
Concurrent Session 4: Targeting the Innate Immune System
  •  
  • Permission not
    granted for presentation
  •  
  •  
Genetically Engineered Natural Killer Cell Lines For Treatment of Cancer
Hans Klingemann
NantKwest, Inc., Woburn, MA, United States
from 2019 Molecular Targets and Cancer Therapeutics conference on October 28, 2019 4:15 PM-6:00 PM
Concurrent Session 4: Targeting the Innate Immune System
Exploring Approaches to Optimize NK Cell-Based Immunotherapy for Cancer
Richard W Childs
National Heart, Lung, and Blood Institute, Bethesda, MD, United States
from 2019 Molecular Targets and Cancer Therapeutics conference on October 28, 2019 4:15 PM-6:00 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 3 of 3